PMID: 6539877Jul 1, 1984Paper

Verapamil in prophylactic therapy of migraine

Neurology
H G MarkleyR W Piepho

Abstract

We conducted a double-blind, placebo-controlled crossover study of verapamil HCl in the prophylaxis of chronic migraine headaches. Verapamil significantly reduced both headache frequency and duration with few side effects. The drug may be useful for a segment of the migraine population refractory to other prophylactic agents or for those who cannot tolerate the side effects of other drugs.

Citations

Apr 3, 2001·Current Treatment Options in Neurology·Arthur Prensky
Dec 6, 2001·Current Treatment Options in Neurology·Judy C. Lane, David B. Arciniegas
Oct 1, 2003·Current Treatment Options in Neurology·Shazia Afridi, Holger Kaube
Mar 1, 1996·Clinical Therapeutics·T L Skaer
Sep 19, 2001·British Journal of Clinical Pharmacology·V Limmroth, M C Michel
Sep 17, 2002·Cephalalgia : an International Journal of Headache·S D Silberstein, P J Goadsby
Oct 17, 1985·The New England Journal of Medicine·S H Snyder, I J Reynolds
Nov 11, 1993·The New England Journal of Medicine·K M Welch
Feb 18, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tamara PringsheimWerner J Becker
May 25, 2002·CNS Drugs·Seymour Diamond, Richard Wenzel
Jun 12, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Tamara PringsheimUNKNOWN Canadian Headache Society Prophylactic Guidelines Development Group
Jun 9, 2005·Expert Review of Neurotherapeutics·Min-Suk YoonVolker Limmroth
Sep 23, 2009·Expert Review of Neurotherapeutics·Chad A Whyte, Stewart J Tepper
Jan 5, 2002·Expert Opinion on Investigational Drugs·H C Diener, V Limmroth
Feb 23, 2010·Lancet Neurology·Peter J Goadsby, Till Sprenger
Mar 18, 2009·Neurologic Clinics·Stephen D Silberstein
Jun 8, 2012·British Journal of Pharmacology·V Nimmrich, G Gross
May 17, 1991·The American Journal of Medicine·H G Markley
Jan 23, 1987·The American Journal of Cardiology·P L VaghyA Schwartz
Jan 1, 1988·Annals of the New York Academy of Sciences·E L Spierings
Apr 1, 1987·Annals of Neurology·D A Greenberg
Mar 1, 1988·Journal of Clinical Pharmacology·S Diamond, E Millstein
Mar 18, 2004·Otolaryngologic Clinics of North America·Egilius L Spierings
Mar 18, 2004·Otolaryngologic Clinics of North America·Egilius L Spierings
Dec 6, 1985·The American Journal of Cardiology·R W Piepho
Feb 1, 1990·Cephalalgia : an International Journal of Headache·P PicciniU Bonuccelli
Apr 1, 1997·Cephalalgia : an International Journal of Headache·N M RamadanS J Gilkey
Jan 1, 1992·Hypertension·D F SlishA Schwartz
Jul 1, 1987·Drug Intelligence & Clinical Pharmacy·T S Tracy, C D Black
Jan 1, 1986·Acta Pharmacologica Et Toxicologica·K E AnderssonT Ryman
Mar 1, 1990·Postgraduate Medicine·S Diamond
Mar 1, 1988·Drug Intelligence & Clinical Pharmacy·M E SchulerM A Munger
Dec 10, 2003·Expert Opinion on Emerging Drugs·Christian Waeber
Oct 3, 2020·Best Practice & Research. Clinical Anaesthesiology·Ivan UritsOmar Viswanath
Apr 4, 2021·International Journal of Molecular Sciences·Jinsha LiuSepideh Afshar
Apr 9, 2021·Molecular Genetics & Genomic Medicine·Fred Michael CutrerChristopher J Klein
May 19, 2021·Neurology India·Lakshmi N RanganathanShunmugasundaram Kanthimathinathan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.